Nicola Vianelli

9.6k total citations · 1 hit paper
138 papers, 3.9k citations indexed

About

Nicola Vianelli is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Nicola Vianelli has authored 138 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Hematology, 66 papers in Genetics and 27 papers in Immunology. Recurrent topics in Nicola Vianelli's work include Platelet Disorders and Treatments (54 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (45 papers) and Blood groups and transfusion (28 papers). Nicola Vianelli is often cited by papers focused on Platelet Disorders and Treatments (54 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (45 papers) and Blood groups and transfusion (28 papers). Nicola Vianelli collaborates with scholars based in Italy, United Kingdom and United States. Nicola Vianelli's co-authors include Lucia Catani, Michele Baccarani, S Tura, Francesca Palandri, L Gugliotta, Nicola Polverelli, Michèle Cavo, Francesco Zaja, Marta Stanzani and Antonio De Vivo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nicola Vianelli

134 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

2007 486 citations Nicola Vianelli et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicola Vianelli Italy	35	2.1k	1.1k	843	824	595	138	3.9k
Carole B. Miller United States	31	2.1k 1.0×	1.0k 1.0×	1.1k 1.3×	1.0k 1.3×	354 0.6×	108	5.2k
Michael Kiehl Germany	34	1.4k 0.7×	716 0.7×	462 0.5×	793 1.0×	774 1.3×	87	3.6k
Sébastien Maury France	31	1.8k 0.9×	481 0.5×	706 0.8×	795 1.0×	1.1k 1.8×	125	3.7k
M. Boogaerts Belgium	38	2.2k 1.0×	1.0k 1.0×	1.1k 1.3×	1.1k 1.4×	771 1.3×	102	4.8k
Ryotaro Nakamura United States	41	3.0k 1.4×	1.0k 1.0×	404 0.5×	1.0k 1.2×	2.3k 3.9×	219	5.6k
Volker Witt Austria	21	1.0k 0.5×	598 0.6×	470 0.6×	434 0.5×	967 1.6×	61	3.4k
Alessandro Busca Italy	30	1.1k 0.5×	991 0.9×	550 0.7×	880 1.1×	682 1.1×	152	4.0k
Agnès Buzyn France	44	3.0k 1.4×	951 0.9×	483 0.6×	715 0.9×	1.0k 1.7×	137	5.7k
Naoyuki Katayama Japan	35	1.1k 0.5×	428 0.4×	322 0.4×	503 0.6×	1.2k 2.1×	246	3.9k
Phillip Scheinberg United States	41	4.3k 2.0×	1.1k 1.1×	628 0.7×	774 0.9×	2.5k 4.3×	153	7.1k

Countries citing papers authored by Nicola Vianelli

Since Specialization

Citations

This map shows the geographic impact of Nicola Vianelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Vianelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Vianelli more than expected).

Fields of papers citing papers by Nicola Vianelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Vianelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Vianelli. The network helps show where Nicola Vianelli may publish in the future.

Co-authorship network of co-authors of Nicola Vianelli

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Vianelli. A scholar is included among the top collaborators of Nicola Vianelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Vianelli. Nicola Vianelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Fianchi, Luana, Alessandra Borchiellini, Gaetano Giuffrida, et al.. (2024). Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study. Journal of Clinical Medicine. 13(21). 6561–6561.

2.

Cooper, Nichola, Waleed Ghanima, Nicola Vianelli, et al.. (2023). Sustained response off‐treatment in eltrombopag‐treated adult patients with ITP who are refractory or relapsed after first‐line steroids: Primary, final, and ad‐hoc analyses of the Phase II TAPER trial. American Journal of Hematology. 99(1). 57–67. 11 indexed citations

3.

Cojutti, Pier Giorgio, Maddalena Giannella, Beatrice Casadei, et al.. (2023). Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics. 15(3). 1022–1022. 1 indexed citations

4.

Auteri, Giuseppe, et al.. (2023). Sustained response off therapy after fostamatinib: A chronic refractory ITP case report. Heliyon. 9(2). e13462–e13462. 2 indexed citations

5.

Forte, Dorian, Martina Barone, Cristina Morsiani, et al.. (2021). Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease. Journal of Experimental & Clinical Cancer Research. 40(1). 49–49. 14 indexed citations

6.

Barone, Martina, Monica Barone, Francesca Ricci, et al.. (2021). A Specific Host/Microbial Signature of Plasma-Derived Extracellular Vesicles Is Associated to Thrombosis and Marrow Fibrosis in Polycythemia Vera. Cancers. 13(19). 4968–4968. 1 indexed citations

7.

Barone, Martina, Francesca Ricci, Daria Sollazzo, et al.. (2018). Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis. British Journal of Haematology. 185(5). 987–991. 16 indexed citations

8.

Forte, Dorian, Daria Sollazzo, Martina Barone, et al.. (2018). Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34⁺Cells. Mediators of Inflammation. 2018. 1–14. 3 indexed citations

9.

Palandri, Francesca, Lucia Catani, Giuseppe Auteri, et al.. (2018). Understanding how older age drives decision‐making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients. British Journal of Haematology. 184(3). 424–430. 14 indexed citations

10.

Stanzani, Marta, et al.. (2017). Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies. Antimicrobial Agents and Chemotherapy. 61(9). 16 indexed citations

11.

Sollazzo, Daria, Dorian Forte, Nicola Polverelli, et al.. (2016). Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly. Mediators of Inflammation. 2016. 1–7. 23 indexed citations

12.

Fernandez, Ignacio Javier, Marta Stanzani, Giulia Tolomelli, et al.. (2011). Sinonasal Risk Factors for the Development of Invasive Fungal Sinusitis in Hematological Patients: Are they Important?. Allergy & Rhinology. 2(1). 6–11. 12 indexed citations

13.

Zaja, Francesco, Marta Lisa Battista, Marco Montagna, et al.. (2008). Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Haematologica. 93(6). 930–933. 78 indexed citations

14.

Stanzani, Marta, Fabio Tumietto, Nicola Vianelli, & Michele Baccarani. (2007). Update on the treatment of disseminated fusariosis: Focus on voriconazole.. PubMed. 3(6). 1165–73. 45 indexed citations

15.

Catani, Lucia, Luigi Gugliotta, Davide Gibellini, et al.. (1998). Megakaryocyte progenitors derived from bone marrow or G‐CSF‐mobilized peripheral blood CD34⁺ cells show a distinct phenotype and responsiveness to interleukin‐3 (IL‐3) and PEG‐recombinant human megakaryocyte growth and development factor (PEG‐rHuMGDF). British Journal of Haematology. 100(1). 207–218. 8 indexed citations

16.

Tazzari, Pier Luigi, Francesca Ricci, Nicola Vianelli, et al.. (1995). Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. Annals of Hematology. 70(5). 267–272. 1 indexed citations

17.

Tazzari, Pier Luigi, Francesca Ricci, Nicola Vianelli, et al.. (1995). Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. Annals of Hematology. 70(5). 267–272. 12 indexed citations

18.

Gugliotta, L, et al.. (1995). Negligible hemostatic toxicity of intermediate-dose Erwinase in adult patients with acute lymphoblastic leukemia: preliminary data.. PubMed. 79(6). 546–9. 5 indexed citations

19.

Mazza, Patrizio, Monica Bocchia, Fabio Tumietto, et al.. (1992). Recombinant interleukin‐2 (rIL‐2) in acquired immune deficiency syndrome (AIDS): Preliminary report in patients with lymphoma associated with HIV infection. European Journal Of Haematology. 49(1). 1–6. 12 indexed citations

20.

Finelli, Carlo, et al.. (1988). Ciclosporin A in idiopathic and CLL-associated pure red cell aplasia.. PubMed. 72(6). 537–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact